How to Interpret Culture and Sensitivity Results: Colony Count Significance
For urinary tract infections, ≥50,000 CFU/mL from a catheterized specimen is the appropriate threshold for diagnosing UTI in most cases, though ≥10,000 CFU/mL may be significant in symptomatic patients with pyuria. 1, 2
Colony Count Thresholds by Specimen Type
Urine Cultures
Collection method determines the significant colony count:
- Catheterized specimens: ≥50,000 CFU/mL of a single uropathogen 1, 2
- Suprapubic aspiration: Any growth is significant; most true UTIs show ≥100,000 CFU/mL 2
- Clean-catch/midstream: ≥100,000 CFU/mL traditionally used, though this has limitations 2
- Bag specimens: Not reliable for positive results—85% false-positive rate even at ≥100,000 CFU/mL 3
Critical caveat: Recent evidence supports that 10,000 CFU/mL in catheterized specimens may represent true infection when accompanied by pyuria (≥10 WBC/mm³ or ≥5 WBC/HPF) and symptoms 4. The 50,000 CFU/mL threshold was adopted to reduce false positives, but may miss 12-30% of true infections 1, 2.
Fungal Cultures
No quantitative cutoffs exist for fungal cultures 5:
- Sterile sites: Even a single colony is significant
- Non-sterile sites: High colony counts do NOT necessarily prove invasive infection—may represent colonization
- Context matters: immunocompetent patient with Aspergillus in sputum = likely colonization; immunosuppressed patient = likely invasive disease 5
Other Infections
Diabetic foot infections: No specific colony count threshold—tissue specimens preferred over swabs 6
Stool cultures: Presence/absence matters more than quantity for enteric pathogens 7
Distinguishing True Infection from Contamination
Key Indicators of True Infection
Must have BOTH organism growth AND evidence of inflammation:
Pyuria (for UTI):
- ≥10 WBC/mm³ on enhanced urinalysis, OR
- ≥5 WBC/HPF on centrifuged specimen, OR
- Positive leukocyte esterase on dipstick 2
Single organism vs. polymicrobial growth:
Organism type matters:
Common Pitfalls
Bag urine specimens in infants: Positive predictive value only 15% at 5% UTI prevalence—always confirm positive bag specimens with catheterized culture 3
Low colony counts with bacteremia: 18% of patients with UTI-associated bacteremia have <100,000 CFU/mL; 12% have 10,000-100,000 CFU/mL 9
Pseudomonas isolation: Often a colonizer, not pathogen—only treat if severe infection, failed prior therapy, or high local prevalence 8
Interpreting Susceptibility Results
When to Follow Susceptibility Testing
Start with empiric therapy, then adjust based on:
- Clinical response to initial treatment
- Susceptibility patterns of isolated organism
- Site-specific pharmacokinetic considerations 10, 11
If patient improving on empiric therapy: May continue even if organism shows "resistance" in vitro—clinical response trumps lab results 8
If patient not improving: Broaden coverage to include all isolated organisms, even those typically considered contaminants 8
Critical Resistance Patterns
MRSA: Prevalence 5-30% in diabetic foot infections—consider empiric coverage if severe infection, prior MRSA, or high local prevalence 8
Fluoroquinolone-resistant Shigella: Avoid fluoroquinolones if ciprofloxacin MIC ≥0.12 μg/mL even if reported "susceptible" 7
ESBL producers: Consider in patients with healthcare exposure or from high-prevalence regions 8
Timing Considerations
Obtain cultures BEFORE starting antibiotics whenever possible 5—even a single dose can render cultures negative
If cultures obtained after antibiotics started: Expect decreased sensitivity; negative culture does not rule out infection 5